Abstract
Introduction

45
MicroRNAs (miRNAs) are small non-coding RNA molecules that have important regulatory 46 roles in gene expression by targeting mRNAs for cleavage or translational repression.
47
Incomplete sequence complementarity between the miRNA and the target mRNA can induce 48 translational repression without mRNA degradation, whereas a higher degree of sequence 49 complementarity leads to catalytic degradation of the target mRNA (2). The human genome 50 encodes more than 1000 miRNAs, and over 50 % of cellular mRNAs have been estimated to 51 be under miRNA regulation (7). miRNAs have important regulatory roles in development, 52 cell proliferation, differentiation, apoptosis, and stress responses, explaining why 53 dysregulation of miRNA expression is associated with many diseases, most notably cancer 54 (6). Preparation of replication competent SFVs has been previously described (26 
Materials and Methods
118
For virus titration of mouse tissues half of the brains and part of the livers were snap frozen in 119 liquid nitrogen and stored at -70°C until homogenized in 1% BSA/PBS for virus titration.
120
The homogenate was centrifuged at 4500 x g, + 4 °C for 5 minutes and the supernatant was 121 used for titration. Blood samples were drawn from mice immediately after euthanasia and 122 serum was separated using Microvette 500 Z-gel tubes (Sarstedt, Nümbrecht, Germany).
123
Titration was done as above with plaque analysis in Vero(B) cells.
124
Cell viability assays
125
All cell lines tested were infected with SFV4, SFV4-miRT122 or SFV4-miRT124 at a nsp3 and nsp4 (data not shown), and this strategy was chosen for all subsequent experiments.
215
This intergenic strategy for insertion of six copies of miR122 (SFV4-miRT122) or miR124
216
(SFV4-miRT124) target elements is schematically presented in Figure 1 .
217
To confirm correct proteolytic processing of the nsp3 and nsp4 in cells infected with these To evaluate the capacity of miRNA-targeting to restrict SFV replication we infected miR122- indicating that SFV4-miRT124 replication was severely attenuated in the CNS.
272
To examine if the course of infection in the single mouse that developed severe neurologic SFV-miRT122 and SFV4 reached 10 5 to 10 6 PFU/g (100-to 1000-fold higher).
290
To evaluate the antiviral intereferon responses in the CNS of these mice, we measured the 
Discussion
332
Here we show that neuropathogenicity of Semliki forest virus can be selectively attenuated observed after SFV4-miRT124 infection was not due to peripheral attenuation of the virus.
346
The initial peripheral replication of our viruses did not induce detectable levels of IFN-β in and slow process, and does not pose a major threat to the utility of this approach in general.
361
Of note, we found that a prior infection of mice with SFV4-miRT124 could provide antiviral 
370
To further characterize the basis of the reduced neuropathogenicity associated with systemic 371 infection with a miR124-controlled virus, we also tested intracranial administration of SFV4- 
